Latest S-1 registration statements

Liminatus Pharma, a pre-clinical stage biotech, completed its business combination with Iris Acquisition Corp., securing initial funding but still faces significant capital needs and a going concern warning.

Katapult Holdings, Inc. filed an S-1 registration statement for the resale of up to 22 million shares by selling securityholders, stemming from a recent debt refinancing and warrant exercises.

Chenghe Acquisition III Co., a blank check company, filed an amended S-1 registration statement for its initial public offering of 11 million units at $10.00 per unit, targeting Asian markets.

Caedryn Acquisition Corporation I, a blank check company, has filed an S-1 registration statement for an initial public offering of 6,000,000 units at $10.00 each, targeting businesses in the artificial intelligence and financial technology sectors.

zSpace, Inc., an AR/VR educational technology provider, filed an S-1 registration statement for the resale of up to 6.5 million common shares by Tumim Stone Capital LLC, while disclosing ongoing net losses, negative cash flows, and substantial doubt about its ability to continue as a going concern.

Safe & Green Holdings Corp. filed an S-1/A to register 20.4 million shares for resale by a selling stockholder, detailing recent capital raises, strategic acquisitions, and ongoing efforts to regain and maintain Nasdaq listing compliance.

Tivic Health Systems, Inc. filed an amended registration statement to allow a selling stockholder, Helena Global Investment Opportunities 1 Ltd., to resell up to 602,245 shares of common stock, stemming from a recent $8.4 million preferred stock and warrant purchase agreement.

Cingulate Inc. has entered into a new $25 million committed equity financing agreement with Lincoln Park Capital Fund, LLC to fund its biopharmaceutical pipeline, including the anticipated NDA submission for its lead ADHD candidate, CTx-1301.

Aptevo Therapeutics Inc. has filed an S-1 registration statement to allow a selling stockholder to resell up to 8.25 million shares, enabling the company to potentially raise up to $25 million through a Standby Equity Purchase Agreement to fund its clinical-stage oncology pipeline.

Seneca Bancorp, Inc. is proceeding with its mutual holding company to stock holding company conversion, offering shares at $10.00 each to raise capital for strategic growth and enhanced liquidity, despite recent net losses.

Actuate Therapeutics, a clinical-stage biopharmaceutical company, filed an S-1 registration statement for the resale of 1.33 million common shares by existing stockholders, highlighting significant financial challenges including a going concern warning.

Shoulder Innovations, a commercial-stage medical technology company focused on shoulder surgical care, is pursuing an initial public offering of 5 million shares to fund its rapid growth, despite reporting increasing net losses and significant operating expenses.

Starry Sea Acquisition Corp has filed an S-1/A amendment, primarily to include updated exhibits detailing its proposed unit offering, trust account management, and legal opinions for its initial public offering.

McKinley Acquisition Corporation, a newly formed blank check company, filed an amended S-1 registration statement for its initial public offering of 15 million units at $10.00 per unit, aiming to raise $150 million to pursue a business combination in progressive, innovation-driven sectors.

ENDRA Life Sciences Inc. is launching a public offering of common stock and warrants to raise approximately $95.6 million, primarily to fund a new, untested cryptocurrency treasury strategy while continuing development of its core ultrasound technology.

Nova LifeStyle, Inc. is launching a public offering of common stock and warrants to raise up to $9.0 million, as it grapples with a 'going concern' warning, ongoing net losses, and a looming Nasdaq minimum bid price compliance deadline.

BM Acquisition Corp., a Cayman Islands-based blank check company, filed an amended S-1 registration statement for its initial public offering of 6 million units at $10.00 each, aiming to raise $60 million to acquire an operating business in Southeast Asia with annual revenues between $15 million and $30 million.

HeartCore Enterprises, a Tokyo-based software company, has entered into agreements for up to $25 million in equity financing and convertible preferred stock to bolster its growth initiatives and address critical Nasdaq listing deficiencies, though these actions will result in substantial shareholder dilution.

Lionsgate Studios Corp. has finalized its separation from Starz Entertainment Corp., establishing itself as an independent, publicly traded content studio focused on film and television production and distribution.

Wellgistics Health, a healthcare and pharmaceutical holding company, has filed an S-1 registration statement for a public offering of common stock and warrants, while also disclosing a new strategic plan to integrate blockchain technology and hold XRP as a primary treasury reserve asset.

Venus Concept Inc. has filed an Amendment No. 1 to its Form S-1 Registration Statement, primarily to incorporate the consent of its independent registered public accounting firm, MNP LLP.

NusaTrip Incorporated filed an S-1/A amendment to update exhibit information, disclose estimated public offering expenses, and detail recent unregistered securities sales, including convertible note conversions.

Shoulder Innovations, a medical technology company focused on shoulder surgical care, filed an S-1/A for its initial public offering, showcasing significant revenue growth but also increasing net losses and detailing a recent $40 million convertible note financing.

Highview Merger Corp., a Cayman Islands-exempted blank check company, filed an S-1 registration statement for an initial public offering of 20 million units at $10.00 each, aiming to raise $200 million for a business combination.

Linkhome Holdings Inc. has filed an S-1MEF registration statement to increase the number of common stock shares offered in its initial public offering by 287,500, including over-allotment options.

Cyclacel Pharmaceuticals, a clinical-stage biopharmaceutical company, has filed an S-1 registration statement for the resale of common stock by existing shareholders, revealing a strategic pivot to focus solely on its plogosertib program, a significant acquisition, and ongoing financial viability concerns.

Karman Holdings Inc. filed an S-1MEF to increase the number of common stock shares offered by selling stockholders in its public offering by 1,150,000 shares.

Quantumsphere Acquisition Corporation, a Cayman Islands exempted blank check company, filed an amended S-1 registration statement detailing its $60 million initial public offering, significant dilution for public shareholders, and substantial risks related to its management's ties to China and involvement in multiple SPACs.

Westin Acquisition Corp., a newly formed blank check company, filed an S-1 registration statement for an initial public offering of 5,000,000 units at $10.00 per unit, aiming to raise $50 million for a business combination within 18 months.

Advanced Biomed Inc., a pre-revenue biotechnology company, filed an S-1 registration statement for the resale of up to 40 million shares by a selling stockholder under a $25 million equity line of credit, while grappling with persistent net losses and a Nasdaq minimum bid price deficiency.